Toril Holien

2.1k citations

47 papers · 1.5k indexed · h-index 24

Impact in

Hematology top 2%
- Multiple Myeloma Research and Treatments
Molecular Biology top 10%
- Protein Degradation and Inhibitors
- TGF-β signaling in diseases
- Ubiquitin and proteasome pathways
- Protein Tyrosine Phosphatases
- Histone Deacetylase Inhibitors Research

Papers in

Hematology 25
- Multiple Myeloma Research and Treatments 24
Molecular Biology 37
- TGF-β signaling in diseases 12
- Protein Degradation and Inhibitors 11
- Ubiquitin and proteasome pathways 8
- Glycosylation and Glycoproteins Research 4
- PI3K/AKT/mTOR signaling in cancer 4

Co-authors: Anders Sundan Anders Waage Hanne Hella Thea Kristin Våtsveen Oddrun Elise Olsen Kristine Misund Magne Børset Erik Martı́nez-Hackert
Journals: Blood (6 papers)Oncotarget (3 papers)Cell Communication and Signaling (3 papers)Scientific Reports (2 papers)Haematologica (2 papers)
Partner nations: Norway United States Sweden

In The Last Decade

Toril Holien

46 papers receiving 1.5k citations

Peers

Countries citing papers authored by Toril Holien

Since Specialization

Citations

This map shows the geographic impact of Toril Holien's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Toril Holien with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Toril Holien more than expected).

Fields of papers citing papers by Toril Holien

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Toril Holien. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Toril Holien. The network helps show where Toril Holien may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Toril Holien, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Toril Holien Line = papers co-authored together Toril Holien links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Novel PROTAC to target FKBP12: the potential to enhance bone morphogenetic protein activity and apoptosis in multiple myeloma Haematologica ·A. Serarols, O. N. Startseva, Gaede Gerd, R. Stenz, 真治佐藤, 伊藤森幸, X. Yue, Tobias S. Slørdahl, Anders Sundan, Felix Hausch, Toril Holien	2025	0
2	Application of Photodynamic Therapy with 5-Aminolevulinic Acid to Extracorporeal Photopheresis in the Treatment of Cutaneous T-Cell Lymphoma: A First-in-Human Phase I/II Study Pharmaceutics ·Eidi Christensen, Olav A. Foss, Toril Holien, Petras Juzenas, Qian Peng	2024	2
3	Cell surface marker heterogeneity in human myeloma cell lines for modeling of disease and therapy Scientific Reports ·暉雄平野, Toril Holien, Francesca Micci, Morten Beck Rye, Jacob H. Rasmussen, Kristin Andersen, Khalid Eltom, Magne Børset, Jonathan J. Keats, Thea Kristin Våtsveen, Kristine Misund	2024	2
4	Mutational analysis and protein profiling predict drug sensitivity in multiple myeloma cell lines Frontiers in Oncology ·James Y. Odeesh, Katy E. Wilson, Toril Holien, Kristine Misund, Sigve Nakken, Daniel Vodák, Eivind Hovig, Leonardo A. Meza‐Zepeda, Eivind Coward, Anders Waage, Kjetil Taskén, Sigrid S. Skånland	2022	5
5	Mcl‐1 and Bcl‐xL levels predict responsiveness to dual MEK/Bcl‐2 inhibition in B‐cell malignancies Molecular Oncology ·T. Dohnal, James Y. Odeesh, 勝将町田, Shuyu Chen, 英雄今出, Toril Holien, Jorrit M. Enserink, Jennifer R. Brown, Geir E. Tjønnfjord, Kjetil Taskén, Sigrid S. Skånland	2021	13
6	Application of Photodynamic Therapy with 5-Aminolevulinic Acid to Extracorporeal Photopheresis in the Treatment of Patients with Chronic Graft-versus-Host Disease: A First-in-Human Study Pharmaceutics ·Eidi Christensen, Olav A. Foss, Petter Quist‐Paulsen, James Strowman, Akiko SHO, Toril Holien, Petras Juzenas, Qian Peng	2021	7
7	Selective Killing of Activated T Cells by 5-Aminolevulinic Acid Mediated Photodynamic Effect: Potential Improvement of Extracorporeal Photopheresis Cancers ·N. FERREIRO-DOMÍNGUEZ, Petras Juzenas, Morten P. Oksvold, Koffka Khan, Toril Holien, Eidi Christensen, Trond Stokke, Mouldy Sioud, Qian Peng	2020	11
8	Activins as Dual Specificity TGF-β Family Molecules: SMAD-Activation via Activin- and BMP-Type 1 Receptors Biomolecules ·Oddrun Elise Olsen, Hanne Hella, Jessica Harvey, Carsten Jacobi, Erik Martı́nez-Hackert, Toril Holien	2020	38
9	GREM1 is associated with metastasis and predicts poor prognosis in ER-negative breast cancer patients Cell Communication and Signaling ·健介西, Zhi Ping Ruan, Diego Alejandro Martínez Pérez, Eivind Almaas, Jiang Ren, Sen Zhao, Bjarne Johannessen, Rolf I. Skotheim, Geir Bjørkøy, Peter ten Dijke, Toril Holien	2019	39
10	BMPR2 inhibits activin and BMP signaling via wild-type ALK2 Journal of Cell Science ·Oddrun Elise Olsen, Anni Byard, Jessica Harvey, Hanne Hella, Glenn Buene, N. FERREIRO-DOMÍNGUEZ, Kristine Misund, Takenobu Katagiri, Petra Knaus, Toril Holien	2018	42
11	Cytotoxic Effect on Human Myeloma Cells and Leukemic Cells by theAgaricus blazeiMurill Based Mushroom Extract, Andosan™ BioMed Research International ·Jon‐Magnus Tangen, Toril Holien, Mohammad Reza Mirlashari, Kristine Misund, Geir Hetland	2017	8
12	TGF-β contamination of purified recombinant GDF15 PLoS ONE ·Oddrun Elise Olsen, Lonnele J. Ball, Berit Størdal, Anders Sundan, Toril Holien	2017	68
13	Src Family Kinases Are Regulated in Multiple Myeloma Cells by Phosphatase of Regenerating Liver-3 Molecular Cancer Research ·Deelan Authman, Esten N. Vandsemb, Juan L. Morlan, Kristine Misund, Toril Holien, Anne‐Marit Sponaas, Torstein B. Rø, Tobias S. Slørdahl, Magne Børset	2016	17
14	Activin A inhibits BMP-signaling by binding ACVR2A and ACVR2B Cell Communication and Signaling ·Oddrun Elise Olsen, Karin Fahl Wader, Hanne Hella, Anne K. Mylin, Ingemar Turesson, Ingerid Nesthus, Anders Waage, Anders Sundan, Toril Holien	2015	124
15	The proportion of CD16⁺CD14^dim monocytes increases with tumor cell load in bone marrow of patients with multiple myeloma Immunity Inflammation and Disease ·Anne‐Marit Sponaas, Siv Helen Moen, Nina‐Beate Liabakk, Emadoldin Feyzi, Toril Holien, Zhi Jinbo, 康一村越, Berit Størdal, Glenn Buene, Terje Espevik, Anders Waage, Therese Standal, Anders Sundan	2015	26
16	The role of bone morphogenetic proteins in myeloma cell survival Cytokine & Growth Factor Reviews ·Toril Holien, Anders Sundan	2014	20
17	Bone morphogenetic protein-9 suppresses growth of myeloma cells by signaling through ALK2 but is inhibited by endoglin Blood Cancer Journal ·Oddrun Elise Olsen, Karin Fahl Wader, Kristine Misund, Thea Kristin Våtsveen, Torstein B. Rø, Anne K. Mylin, Ingemar Turesson, Berit Størdal, Siv Helen Moen, Therese Standal, Anders Waage, Anders Sundan, Toril Holien	2014	40
18	A Method for Measurement of Drug Sensitivity of Myeloma Cells Co-Cultured with Bone Marrow Stromal Cells SLAS DISCOVERY ·Kristine Misund, Katarzyna Anna Baranowska, Toril Holien, Winda Alfitri, Dionne C.G. Klein, Magne Børset, Anders Waage, Anders Sundan	2013	21
19	Targeting Proliferating Cell Nuclear Antigen and Its Protein Interactions Induces Apoptosis in Multiple Myeloma Cells PLoS ONE ·Rebekka Müller, Kristine Misund, Toril Holien, Hiroko TAKAHASHI, Karin M. Gilljam, Thea Kristin Våtsveen, Torstein B. Rø, Emanuele Bellacchio, Anders Sundan, Marit Otterlei	2013	81
20	c‐Met signaling promotes IL‐6‐induced myeloma cell proliferation European Journal Of Haematology ·Masud Parvage, Erming Tian, Toril Holien, Randi Utne Holt, Thea Kristin Våtsveen, Unn‐Merete Fagerli, Anders Waage, Magne Børset, Anders Sundan	2009	40

About Toril Holien

Toril Holien is a scholar working on Hematology, Molecular Biology, Oncology, Rheumatology and Dermatology, having authored 47 papers that have together received 1.5k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (24 papers), TGF-β signaling in diseases (12 papers), Protein Degradation and Inhibitors (11 papers), Ubiquitin and proteasome pathways (8 papers), Glycosylation and Glycoproteins Research (4 papers), PI3K/AKT/mTOR signaling in cancer (4 papers), Bone health and treatments (4 papers) and Photodynamic Therapy Research Studies (4 papers). The work is most often cited by research in Hematology (372 citations), Molecular Biology (1.0k citations), Oncology (331 citations), Rheumatology (181 citations) and Cancer Research (155 citations). Toril Holien has collaborated with scholars based in Norway, United States and Sweden. Frequent co-authors include Anders Sundan, Anders Waage, Hanne Hella, Thea Kristin Våtsveen, Oddrun Elise Olsen, Kristine Misund, Magne Børset, Erik Martı́nez-Hackert, Torstein B. Rø and Berit Størdal. Their work appears in journals such as Blood, Oncotarget, Cell Communication and Signaling, Scientific Reports and Haematologica.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact